Exelixis (EXEL) EVP Haley granted 40,459 RSUs vesting from 2027

Rhea-AI Filing Summary

Haley Patrick J. reported acquisition or exercise transactions in this Form 4 filing.

EXELIXIS, INC. executive Patrick J. Haley, EVP, Commercial, received an equity grant of 40,459 restricted stock units (RSUs) of common stock. The RSUs were granted under the Exelixis, Inc. 2017 Equity Incentive Plan and carry no purchase price.

The award will vest as to one-quarter of the original RSU share amount on May 15, 2027, and one-quarter on each May 15 thereafter until fully vested. Following this grant, a total of 422,367 shares of common stock are scheduled to be issued to Haley upon vesting of RSUs and a performance-based restricted stock unit award granted on March 31, 2025.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Haley Patrick J.

Role EVP, Commercial

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	40,459	$0.00	--

Holdings After Transaction: Common Stock — 422,367 shares (Direct)

Footnotes (1)

1. Represents shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon the vesting of restricted stock units ("RSUs"). The RSUs were granted to the Reporting Person on the Transaction Date pursuant to the Exelixis, Inc. 2017 Equity Incentive Plan. The RSUs will vest as to 1/4th of the original number of shares subject to the RSU award on May 15, 2027 and thereafter as to 1/4th of the original number of shares subject to the RSU award on each May 15th until fully vested. Includes 422,367 shares of Common Stock that will be issued to the Reporting Person upon vesting of RSUs and the performance-based restricted stock unit award granted to the Reporting Person on March 31, 2025 ("One-Time Award PSUs"). Each RSU is the economic equivalent of one share of Common Stock and each One-Time Award PSU represents a contingent right to receive one share of Common Stock.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Haley Patrick J.

(Last) (First) (Middle)

C/O EXELIXIS, INC.

1851 HARBOR BAY PARKWAY

(Street)

ALAMEDA CA 94502

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
EXELIXIS, INC. [ EXEL ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP, Commercial

3. Date of Earliest Transaction (Month/Day/Year)
02/26/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/26/2026(1)		A		40,459(1)	A	$0	422,367(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon the vesting of restricted stock units ("RSUs"). The RSUs were granted to the Reporting Person on the Transaction Date pursuant to the Exelixis, Inc. 2017 Equity Incentive Plan. The RSUs will vest as to 1/4th of the original number of shares subject to the RSU award on May 15, 2027 and thereafter as to 1/4th of the original number of shares subject to the RSU award on each May 15th until fully vested.

2. Includes 422,367 shares of Common Stock that will be issued to the Reporting Person upon vesting of RSUs and the performance-based restricted stock unit award granted to the Reporting Person on March 31, 2025 ("One-Time Award PSUs"). Each RSU is the economic equivalent of one share of Common Stock and each One-Time Award PSU represents a contingent right to receive one share of Common Stock.

Remarks:

	/s/ Nina Ayer, Attorney in Fact	03/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What equity award did EXEL executive Patrick J. Haley report on this Form 4?

Patrick J. Haley reported a grant of 40,459 restricted stock units (RSUs) of Exelixis common stock. The RSUs were awarded with a zero-dollar price per share under the company’s 2017 Equity Incentive Plan, reflecting stock-based compensation rather than an open-market purchase.

When do Patrick J. Haley’s newly granted EXEL RSUs vest?

The RSUs vest in four equal installments beginning May 15, 2027. One-quarter of the original 40,459 RSUs vests on that date, with additional one-quarter portions vesting on each subsequent May 15 until the entire award is fully vested.

How many EXEL shares are scheduled to be issued to Patrick J. Haley after all awards vest?

After this grant, 422,367 shares of Exelixis common stock are scheduled to be issued upon vesting of RSUs and a performance-based restricted stock unit award. Each RSU and each performance unit represents the right to receive one share of common stock.

What is the nature of Patrick J. Haley’s ownership in this EXEL Form 4?

The filing shows direct ownership of Exelixis common stock and equity awards. The 40,459 new RSUs and prior RSUs and performance-based units together total 422,367 shares that may be delivered to him upon satisfaction of the vesting conditions.

Under which plan were Patrick J. Haley’s EXEL RSUs granted?

The 40,459 RSUs were granted pursuant to the Exelixis, Inc. 2017 Equity Incentive Plan. This plan provides equity-based awards such as restricted stock units to executives and employees, aligning a portion of their compensation with the company’s common stock performance.